Moneycontrol
HomeNewsBusinessMarkets39 PMSes outperformed Nifty in October; pharma-focused fund tops the list
Trending Topics

39 PMSes outperformed Nifty in October; pharma-focused fund tops the list

Around 39 PMS schemes managed to outperform Nifty with Kotak AMC’s Pharma fund topping the list, returning 6.8 percent during the month gone by, data collated by Pmsbazaar.com, an online portal used for PMS comparison, showed

November 11, 2019 / 10:00 IST
Story continues below Advertisement

The Nifty50 rallied about 3.5 percent in the month of October on the back of various measures taken by the government to revive the economy and kick-start investment cycle, as well as, positive global cues on the trade war front.

In the same time, around 39 PMS schemes managed to outperform the index with Kotak AMC’s Pharma fund topping the list, returning 6.8 percent during the month gone by, data collated by Pmsbazaar.com, an online portal used for PMS comparison, showed.

Story continues below Advertisement

The investment objective of the Kotak AMC Pharma sectoral fund is to generate capital appreciation through investments in equities with a medium to long-term perspective. The strategy is to invest in pharma and healthcare-related companies with 10-20 stocks.

The fund not only outperformed the Nifty50 in October but also the Nifty Pharma index which rose 4.3 percent in the same period.